Bovie Medical Corporation Announces FDA Clearance to Market Patent Pending Suture Removal Device.MELVILLE, N.Y. -- Bovie Medical Corporation (the "Company") (Amex: BVX BVX Bulk Viscosity of Xenon ), a manufacturer and marketer of electrosurgical products, today announced that it has received U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) 510(K) clearance to market its "In-a-Flash" Suture suture /su·ture/ (soo´cher) 1. sutura. 2. a stitch or series of stitches made to secure apposition of the edges of a surgical or traumatic wound. 3. to apply such stitches. 4. Removal device. The device is designed to remove sutures with a tension free cut and is anticipated to be utilized in various human and animal medical procedures. The Company plans to market and distribute the device through its established and growing distribution network. Commenting on the FDA clearance to market, J. Robert Saron, president of Bovie Medical's wholly-owned subsidiary Aaron Medical, stated, "We are pleased with the progress the Company is making developing proprietary and innovative medical technologies. We will be introducing the 'In-a-Flash' Suture Removal device at the Health Industry Distributors Association show (HIDA HIDA Health Industry Distributors Association HIDA Hepatobiliary Iminodiacetic Acid (scan to evaluate galbladder) HIDA High Intensity Directional Acoustics (American Technology Corporation and Carver Corporation) ) in Chicago, IL. from September 19-21, 2006. The HIDA show is the largest medical distributor meeting that Bovie attends in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. ." This document may contain some forward looking statements, particularly regarding operational prospects in 2006 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company's SEC filings. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion